Oregon Business News - Page 2

PORTLAND, Ore., Sept. 6, 2019 (SEND2PRESS NEWSWIRE) — Move For Hunger and the Portland Relocation Council announced today that the first-ever Rose City Truck Pull, presented by Chipman Relocation & Logistics, will take place on Thursday, September 12 from 1 -5 p.m.. The event, in which teams of 5-10 will compete to see who can pull a moving truck 100 feet in the fastest time.

PENDLETON, Ore., May 30, 2019 (SEND2PRESS NEWSWIRE) — The Bonanza Art Antiques & Gourmet Expo is coming to the Pendleton Convention Center on June 7 and 8, 2019. This inaugural event will feature an eclectic mix of artists, antique and vintage dealers, small gourmet food producers, and offer tastes from several Oregon wineries, breweries and other craft beverage houses.

PORTLAND, Ore., May 9, 2019 (SEND2PRESS NEWSWIRE) — Mold Inspection Sciences (MIS), one of the state’s largest mold inspection and testing companies, has announced the publication of an infographic now available to view and download from the Mold Inspection Sciences website.

PORTLAND, Ore., May 6, 2019 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Mohima Sanyal has been named its 2019 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care/

PORTLAND, Ore., Nov. 27, 2018 (SEND2PRESS NEWSWIRE) — Paragon BioTeck announces holiday event, “A Night to Remember,” scheduled Friday, Dec. 7, 2018 from 5:30 – 8 p.m. in Eugene, Ore. The event delivers a magical night of holiday sights and sounds for the families of Pearl Buck Preschool.

PORTLAND, Ore., April 13, 2018 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.

PORTLAND, Ore., April 2, 2018 (SEND2PRESS NEWSWIRE) — XG Communities, a premier provider of wireless marketing plans and engineering services for cities and municipalities across the United States, has been awarded an exclusive wireless marketing agreement with the City of Portland.

PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

PORTLAND, Ore., April 12, 2017 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

PORTLAND, Ore., Nov. 17, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today that it has received CE mark approval for the recently FDA cleared Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug. CE mark approval is recognized and associated with safety and performance in multiple countries.

PORTLAND, Ore., Oct. 16, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announces that it will be formally launching its corporate citizenship initiative coined, Paragon Gives. On Sunday October 19, 2014, Paragon BioTeck, will kick off its newly branded corporate social responsibility initiative at the annual American Academy of Ophthalmology conference in Chicago, Ill.

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.

PORTLAND, Ore., June 25, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug.

PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.

PORTLAND, Ore., April 9, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.

PORTLAND, Ore., Oct. 9, 2013 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast(R) range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.